{"DataElement":{"publicId":"3135236","version":"1","preferredName":"Bladder Carcinoma Clinical T Stage","preferredDefinition":"Code to represent the extent of bladder carcinoma in the primary tumor site based on clinical assessment and the staging guidelines from the AJCC edition 7.0.","longName":"2190136v1.0:3135076v1.0","context":"NCIP","contextVersion":"1","DataElementConcept":{"publicId":"2190136","version":"1","preferredName":"Bladder Tumor Clinical T Stage","preferredDefinition":"Information related to the clinical T stage of a bladder tumor.","longName":"BLAD_TUMOR_C_T","context":"NCI Standards","contextVersion":"1","ObjectClass":{"publicId":"2206698","version":"1","preferredName":"Bladder Neoplasm","preferredDefinition":"A distensible musculomembranous organ serving as a receptacle for fluid, as the gallbladder.:(NEE-o-PLAY-zha) Abnormal and uncontrolled cell growth.","longName":"C12414:C3262","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Bladder","conceptCode":"C12414","definition":"The distensible sac-like organ that functions as a reservoir of urine, collecting from the kidneys and eliminating via the urethra.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Neoplasm","conceptCode":"C3262","definition":"A benign or malignant tissue growth resulting from uncontrolled cell proliferation. Benign neoplastic cells resemble normal cells without exhibiting significant cytologic atypia, while malignant cells exhibit overt signs such as dysplastic features, atypical mitotic figures, necrosis, nuclear pleomorphism, and anaplasia. Representative examples of benign neoplasms include papillomas, cystadenomas, and lipomas; malignant neoplasms include carcinomas, sarcomas, lymphomas, and leukemias.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"F37D0429-008F-6787-E034-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-03-29","endDate":null,"createdBy":"SBR","dateCreated":"2005-03-29","modifiedBy":"ONEDATA","dateModified":"2005-03-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"Property":{"publicId":"2207100","version":"1","preferredName":"Clinical T Stage","preferredDefinition":"Having to do with the examination and treatment of patients.:One criteria of the TMN staging system.  T refers to the extent of tumor involvement at the primary site (T, followed by a number indicating size and depth of invasion).","longName":"C25398:C25728","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Clinical","conceptCode":"C25398","definition":"Relating to the examination and treatment of patients dependent on direct observation.  The term may also refer to the institution (clinic) providing this activity.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"T Category","conceptCode":"C25728","definition":"One criteria of the TNM staging system. T refers to the extent of tumor involvement at the primary site (T, followed by a number indicating size and depth of invasion).","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"F37D0429-183F-6787-E034-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-03-29","endDate":null,"createdBy":"SBR","dateCreated":"2005-03-29","modifiedBy":"ONEDATA","dateModified":"2005-03-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ConceptualDomain":{"publicId":"2008537","version":"1","preferredName":"Diagnosis","preferredDefinition":"the process of identifying a disease by the signs and symptoms (NCI Glossary).","longName":"DX","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B205508C-8324-69B0-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-17","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-17","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"E6D3302C-2D93-33F5-E034-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2004-10-19","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2004-10-19","modifiedBy":"TAYLORT","dateModified":"2018-11-28","changeDescription":"10/9/17 tt transferred context/BC; added Reg Status.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ValueDomain":{"publicId":"3135076","version":"1","preferredName":"Bladder Carcinoma Clinical T Stage","preferredDefinition":"A carcinoma arising from the bladder epithelium.  Approximately 90% of the bladder carcinomas are transitional cell carcinomas.  The remainder are squamous cell carcinomas, adenocarcinomas and small cell neuroendocrine carcinomas._Relating to the examination and treatment of patients dependent on direct observation.  The term may also refer to the institution (clinic) providing this activity._One criteria of the TNM staging system.  T refers to the extent of tumor involvement at the primary site (T, followed by a number indicating size and depth of invasion).","longName":"3135076v1.0","context":"NCIP","contextVersion":"1","type":"Enumerated","dataType":"CHARACTER","minLength":null,"maxLength":"5","minValue":null,"maxValue":null,"decimalPlace":null,"PermissibleValues":[{"value":"cT4","valueDescription":"Tumor invades any of the following: prostatic stroma, seminal vesicles, uterus, vagina, pelvic wall, abdominal wall","ValueMeaning":{"publicId":"3135226","version":"1","preferredName":"Tumor invades any of the following: prostatic stroma, seminal vesicles, uterus, vagina, pelvic wall, abdominal wall","longName":"3135226","preferredDefinition":"Tumor invades any of the following: prostatic stroma, seminal vesicles, uterus, vagina, pelvic wall, abdominal wall","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"8FBB4D0A-C7C0-0A8D-E040-BB89AD432FD3","latestVersionIndicator":"Yes","beginDate":"2010-09-08","endDate":null,"createdBy":"REEVESD","dateCreated":"2010-09-08","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"8FBB4D0A-C7D9-0A8D-E040-BB89AD432FD3","beginDate":"2010-09-08","endDate":null,"createdBy":"REEVESD","dateCreated":"2010-09-08","modifiedBy":"ONEDATA","dateModified":"2010-09-08","deletedIndicator":"No"},{"value":"T4b","valueDescription":"Tumor invades pelvic wall, abdominal wall","ValueMeaning":{"publicId":"3135224","version":"1","preferredName":"Tumor invades pelvic wall, abdominal wall","longName":"3135224","preferredDefinition":"Tumor invades pelvic wall, abdominal wall","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"8FBB4D0A-C77A-0A8D-E040-BB89AD432FD3","latestVersionIndicator":"Yes","beginDate":"2010-09-08","endDate":null,"createdBy":"REEVESD","dateCreated":"2010-09-08","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"8FBB4D0A-C793-0A8D-E040-BB89AD432FD3","beginDate":"2010-09-08","endDate":null,"createdBy":"REEVESD","dateCreated":"2010-09-08","modifiedBy":"ONEDATA","dateModified":"2010-09-08","deletedIndicator":"No"},{"value":"pT3b","valueDescription":"Tumor invades perivesical tissue macroscopically (extravesical mass)","ValueMeaning":{"publicId":"3135227","version":"1","preferredName":"Tumor invades perivesical tissue macroscopically (extravesical mass)","longName":"3135227","preferredDefinition":"Tumor invades perivesical tissue macroscopically (extravesical mass)","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"8FBB4D0A-C7E3-0A8D-E040-BB89AD432FD3","latestVersionIndicator":"Yes","beginDate":"2010-09-08","endDate":null,"createdBy":"REEVESD","dateCreated":"2010-09-08","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"8FBB4D0A-C7FC-0A8D-E040-BB89AD432FD3","beginDate":"2010-09-08","endDate":null,"createdBy":"REEVESD","dateCreated":"2010-09-08","modifiedBy":"ONEDATA","dateModified":"2010-09-08","deletedIndicator":"No"},{"value":"pT3a","valueDescription":"Tumor invades perivesical tissue microscopically","ValueMeaning":{"publicId":"3135228","version":"1","preferredName":"Tumor invades perivesical tissue microscopically","longName":"3135228","preferredDefinition":"Tumor invades perivesical tissue microscopically","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"8FBB4D0A-C806-0A8D-E040-BB89AD432FD3","latestVersionIndicator":"Yes","beginDate":"2010-09-08","endDate":null,"createdBy":"REEVESD","dateCreated":"2010-09-08","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"8FBB4D0A-C81F-0A8D-E040-BB89AD432FD3","beginDate":"2010-09-08","endDate":null,"createdBy":"REEVESD","dateCreated":"2010-09-08","modifiedBy":"ONEDATA","dateModified":"2010-09-08","deletedIndicator":"No"},{"value":"cT3","valueDescription":"Tumor invades perivesical tissue","ValueMeaning":{"publicId":"3135229","version":"1","preferredName":"Tumor invades perivesical tissue","longName":"3135229","preferredDefinition":"Tumor invades perivesical tissue","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"8FBB4D0A-C829-0A8D-E040-BB89AD432FD3","latestVersionIndicator":"Yes","beginDate":"2010-09-08","endDate":null,"createdBy":"REEVESD","dateCreated":"2010-09-08","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"8FBB4D0A-C842-0A8D-E040-BB89AD432FD3","beginDate":"2010-09-08","endDate":null,"createdBy":"REEVESD","dateCreated":"2010-09-08","modifiedBy":"ONEDATA","dateModified":"2010-09-08","deletedIndicator":"No"},{"value":"pT2b","valueDescription":"Tumor invades deep muscularis propria (outer half)","ValueMeaning":{"publicId":"3135230","version":"1","preferredName":"Tumor invades deep muscularis propria (outer half)","longName":"3135230","preferredDefinition":"Tumor invades deep muscularis propria (outer half)","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"8FBB4D0A-C84C-0A8D-E040-BB89AD432FD3","latestVersionIndicator":"Yes","beginDate":"2010-09-08","endDate":null,"createdBy":"REEVESD","dateCreated":"2010-09-08","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"8FBB4D0A-C865-0A8D-E040-BB89AD432FD3","beginDate":"2010-09-08","endDate":null,"createdBy":"REEVESD","dateCreated":"2010-09-08","modifiedBy":"ONEDATA","dateModified":"2010-09-08","deletedIndicator":"No"},{"value":"pT2a","valueDescription":"Tumor invades superficial muscularis propria (inner half)","ValueMeaning":{"publicId":"3135231","version":"1","preferredName":"Tumor invades superficial muscularis propria (inner half)","longName":"3135231","preferredDefinition":"Tumor invades superficial muscularis propria (inner half)","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"8FBB4D0A-C86F-0A8D-E040-BB89AD432FD3","latestVersionIndicator":"Yes","beginDate":"2010-09-08","endDate":null,"createdBy":"REEVESD","dateCreated":"2010-09-08","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"8FBB4D0A-C888-0A8D-E040-BB89AD432FD3","beginDate":"2010-09-08","endDate":null,"createdBy":"REEVESD","dateCreated":"2010-09-08","modifiedBy":"ONEDATA","dateModified":"2010-09-08","deletedIndicator":"No"},{"value":"cT2","valueDescription":"Tumor invades muscularis propria","ValueMeaning":{"publicId":"3135232","version":"1","preferredName":"Tumor invades muscularis propria","longName":"3135232","preferredDefinition":"Tumor invades muscularis propria","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"8FBB4D0A-C892-0A8D-E040-BB89AD432FD3","latestVersionIndicator":"Yes","beginDate":"2010-09-08","endDate":null,"createdBy":"REEVESD","dateCreated":"2010-09-08","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"8FBB4D0A-C8AB-0A8D-E040-BB89AD432FD3","beginDate":"2010-09-08","endDate":null,"createdBy":"REEVESD","dateCreated":"2010-09-08","modifiedBy":"ONEDATA","dateModified":"2010-09-08","deletedIndicator":"No"},{"value":"cT1","valueDescription":"Tumor invades subepithelial connective tissue","ValueMeaning":{"publicId":"3135233","version":"1","preferredName":"Tumor invades subepithelial connective tissue","longName":"3135233","preferredDefinition":"Tumor invades subepithelial connective tissue","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"8FBB4D0A-C8B5-0A8D-E040-BB89AD432FD3","latestVersionIndicator":"Yes","beginDate":"2010-09-08","endDate":null,"createdBy":"REEVESD","dateCreated":"2010-09-08","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"8FBB4D0A-C8CE-0A8D-E040-BB89AD432FD3","beginDate":"2010-09-08","endDate":null,"createdBy":"REEVESD","dateCreated":"2010-09-08","modifiedBy":"ONEDATA","dateModified":"2010-09-08","deletedIndicator":"No"},{"value":"cTis","valueDescription":"Carcinoma in situ: \"flat tumor\"","ValueMeaning":{"publicId":"3135234","version":"1","preferredName":"Carcinoma in situ: \"flat tumor\"","longName":"3135234","preferredDefinition":"Carcinoma in situ: \"flat tumor\"","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"8FBB4D0A-C8D8-0A8D-E040-BB89AD432FD3","latestVersionIndicator":"Yes","beginDate":"2010-09-08","endDate":null,"createdBy":"REEVESD","dateCreated":"2010-09-08","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"8FBB4D0A-C8F1-0A8D-E040-BB89AD432FD3","beginDate":"2010-09-08","endDate":null,"createdBy":"REEVESD","dateCreated":"2010-09-08","modifiedBy":"ONEDATA","dateModified":"2010-09-08","deletedIndicator":"No"},{"value":"cTa","valueDescription":"Non-invasive papillary carcinoma","ValueMeaning":{"publicId":"3135235","version":"1","preferredName":"Non-invasive papillary carcinoma","longName":"3135235","preferredDefinition":"Non-invasive papillary carcinoma","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"8FBB4D0A-C8FB-0A8D-E040-BB89AD432FD3","latestVersionIndicator":"Yes","beginDate":"2010-09-08","endDate":null,"createdBy":"REEVESD","dateCreated":"2010-09-08","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"8FBB4D0A-C914-0A8D-E040-BB89AD432FD3","beginDate":"2010-09-08","endDate":null,"createdBy":"REEVESD","dateCreated":"2010-09-08","modifiedBy":"ONEDATA","dateModified":"2010-09-08","deletedIndicator":"No"},{"value":"cT0","valueDescription":"No evidence of primary tumor","ValueMeaning":{"publicId":"2981337","version":"1","preferredName":"No evidence of primary tumor","longName":"2981337","preferredDefinition":"No morphologic evidence of primary tumor, in accordance with TNM classification system guidelines.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"pT0 TNM Finding","conceptCode":"C48758","definition":"No morphologic evidence of primary tumor, in accordance with TNM classification system guidelines.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"7C86ABC7-C701-678D-E040-BB89AD432C56","latestVersionIndicator":"Yes","beginDate":"2010-01-06","endDate":null,"createdBy":"REEVESD","dateCreated":"2010-01-06","modifiedBy":"LUY","dateModified":"2015-01-29","changeDescription":"Concept annotation added for UPitt/TCGA.  Ylu, 01/29/2015.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"8FBB4D0A-C928-0A8D-E040-BB89AD432FD3","beginDate":"2010-09-08","endDate":null,"createdBy":"REEVESD","dateCreated":"2010-09-08","modifiedBy":"ONEDATA","dateModified":"2010-09-08","deletedIndicator":"No"},{"value":"cTX","valueDescription":"Primary tumor cannot be assessed","ValueMeaning":{"publicId":"3040286","version":"1","preferredName":"Primary tumor cannot be assessed","longName":"3040286","preferredDefinition":"A primary tumor TNM finding indicating that the status of the primary tumor cannot be assessed.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"TX TNM Finding","conceptCode":"C48737","definition":"A primary tumor TNM finding indicating that the status of the primary tumor cannot be assessed.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"83221F6F-55E7-6011-E040-BB89AD431C5D","latestVersionIndicator":"Yes","beginDate":"2010-03-31","endDate":null,"createdBy":"REEVESD","dateCreated":"2010-03-31","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":"Concept annotation added for UPitt/TCGA.  Ylu, 01/29/2015.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"8FBB4D0A-C932-0A8D-E040-BB89AD432FD3","beginDate":"2010-09-07","endDate":null,"createdBy":"REEVESD","dateCreated":"2010-09-08","modifiedBy":"ONEDATA","dateModified":"2010-09-08","deletedIndicator":"No"},{"value":"cT4a","valueDescription":"Tumor invades prostatic stroma, uterus, vagina","ValueMeaning":{"publicId":"3152338","version":"1","preferredName":"Tumor invades prostatic stroma, uterus, vagina","longName":"3152338","preferredDefinition":"Tumor invades prostatic stroma, uterus, vagina","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"9339DE92-400C-9BF1-E040-BB89AD437554","latestVersionIndicator":"Yes","beginDate":"2010-10-22","endDate":null,"createdBy":"REEVESD","dateCreated":"2010-10-22","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"9339DE92-4025-9BF1-E040-BB89AD437554","beginDate":"2010-09-08","endDate":null,"createdBy":"REEVESD","dateCreated":"2010-10-22","modifiedBy":"ONEDATA","dateModified":"2010-10-22","deletedIndicator":"No"},{"value":"T4a","valueDescription":"Tumor invades prostatic stroma, uterus, vagina","ValueMeaning":{"publicId":"3152338","version":"1","preferredName":"Tumor invades prostatic stroma, uterus, vagina","longName":"3152338","preferredDefinition":"Tumor invades prostatic stroma, uterus, vagina","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"9339DE92-400C-9BF1-E040-BB89AD437554","latestVersionIndicator":"Yes","beginDate":"2010-10-22","endDate":null,"createdBy":"REEVESD","dateCreated":"2010-10-22","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"BE8A053C-B526-0643-E040-BB89AD436B32","beginDate":"2012-04-25","endDate":null,"createdBy":"COOPERM","dateCreated":"2012-04-25","modifiedBy":"ONEDATA","dateModified":"2012-04-25","deletedIndicator":"No"},{"value":"T4 NOS","valueDescription":"Tumor invades any of the following: prostatic stroma, seminal vesicles, uterus, vagina, pelvic wall, abdominal wall","ValueMeaning":{"publicId":"3135226","version":"1","preferredName":"Tumor invades any of the following: prostatic stroma, seminal vesicles, uterus, vagina, pelvic wall, abdominal wall","longName":"3135226","preferredDefinition":"Tumor invades any of the following: prostatic stroma, seminal vesicles, uterus, vagina, pelvic wall, abdominal wall","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"8FBB4D0A-C7C0-0A8D-E040-BB89AD432FD3","latestVersionIndicator":"Yes","beginDate":"2010-09-08","endDate":null,"createdBy":"REEVESD","dateCreated":"2010-09-08","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"BE8A053C-B53A-0643-E040-BB89AD436B32","beginDate":"2012-04-25","endDate":null,"createdBy":"COOPERM","dateCreated":"2012-04-25","modifiedBy":"ONEDATA","dateModified":"2012-04-25","deletedIndicator":"No"},{"value":"T3b","valueDescription":"Macroscopically (extravesical mass)","ValueMeaning":{"publicId":"3442957","version":"1","preferredName":"Macroscopically (extravesical mass)","longName":"3442957","preferredDefinition":"Macroscopically (extravesical mass)","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"BE8A053C-B544-0643-E040-BB89AD436B32","latestVersionIndicator":"Yes","beginDate":"2012-04-25","endDate":null,"createdBy":"COOPERM","dateCreated":"2012-04-25","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"BE8A053C-B55D-0643-E040-BB89AD436B32","beginDate":"2012-04-25","endDate":null,"createdBy":"COOPERM","dateCreated":"2012-04-25","modifiedBy":"ONEDATA","dateModified":"2012-04-25","deletedIndicator":"No"},{"value":"T3a","valueDescription":"Microscopically","ValueMeaning":{"publicId":"3442958","version":"1","preferredName":"Microscopically","longName":"3442958","preferredDefinition":"Microscopically","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"BE8A053C-B567-0643-E040-BB89AD436B32","latestVersionIndicator":"Yes","beginDate":"2012-04-25","endDate":null,"createdBy":"COOPERM","dateCreated":"2012-04-25","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"BE8A053C-B580-0643-E040-BB89AD436B32","beginDate":"2012-04-25","endDate":null,"createdBy":"COOPERM","dateCreated":"2012-04-25","modifiedBy":"ONEDATA","dateModified":"2012-04-25","deletedIndicator":"No"},{"value":"T2b","valueDescription":"Tumor invades deep muscularis propria (outer half)","ValueMeaning":{"publicId":"3135230","version":"1","preferredName":"Tumor invades deep muscularis propria (outer half)","longName":"3135230","preferredDefinition":"Tumor invades deep muscularis propria (outer half)","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"8FBB4D0A-C84C-0A8D-E040-BB89AD432FD3","latestVersionIndicator":"Yes","beginDate":"2010-09-08","endDate":null,"createdBy":"REEVESD","dateCreated":"2010-09-08","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"BE8A053C-B5A8-0643-E040-BB89AD436B32","beginDate":"2012-04-25","endDate":null,"createdBy":"COOPERM","dateCreated":"2012-04-25","modifiedBy":"ONEDATA","dateModified":"2012-04-25","deletedIndicator":"No"},{"value":"T3 NOS","valueDescription":"Tumor invades perivesical tissue","ValueMeaning":{"publicId":"3135229","version":"1","preferredName":"Tumor invades perivesical tissue","longName":"3135229","preferredDefinition":"Tumor invades perivesical tissue","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"8FBB4D0A-C829-0A8D-E040-BB89AD432FD3","latestVersionIndicator":"Yes","beginDate":"2010-09-08","endDate":null,"createdBy":"REEVESD","dateCreated":"2010-09-08","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"BE8A053C-B594-0643-E040-BB89AD436B32","beginDate":"2012-04-25","endDate":null,"createdBy":"COOPERM","dateCreated":"2012-04-25","modifiedBy":"ONEDATA","dateModified":"2012-04-25","deletedIndicator":"No"},{"value":"T2a","valueDescription":"Tumor invades superficial muscularis propria (inner half)","ValueMeaning":{"publicId":"3135231","version":"1","preferredName":"Tumor invades superficial muscularis propria (inner half)","longName":"3135231","preferredDefinition":"Tumor invades superficial muscularis propria (inner half)","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"8FBB4D0A-C86F-0A8D-E040-BB89AD432FD3","latestVersionIndicator":"Yes","beginDate":"2010-09-08","endDate":null,"createdBy":"REEVESD","dateCreated":"2010-09-08","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"BE8A053C-B5BC-0643-E040-BB89AD436B32","beginDate":"2012-04-25","endDate":null,"createdBy":"COOPERM","dateCreated":"2012-04-25","modifiedBy":"ONEDATA","dateModified":"2012-04-25","deletedIndicator":"No"},{"value":"T2 NOS","valueDescription":"Tumor invades muscularis propria","ValueMeaning":{"publicId":"3135232","version":"1","preferredName":"Tumor invades muscularis propria","longName":"3135232","preferredDefinition":"Tumor invades muscularis propria","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"8FBB4D0A-C892-0A8D-E040-BB89AD432FD3","latestVersionIndicator":"Yes","beginDate":"2010-09-08","endDate":null,"createdBy":"REEVESD","dateCreated":"2010-09-08","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"BE8A053C-B5D0-0643-E040-BB89AD436B32","beginDate":"2012-04-25","endDate":null,"createdBy":"COOPERM","dateCreated":"2012-04-25","modifiedBy":"ONEDATA","dateModified":"2012-04-25","deletedIndicator":"No"},{"value":"T1","valueDescription":"Tumor invades subepithelial connective tissue","ValueMeaning":{"publicId":"3135233","version":"1","preferredName":"Tumor invades subepithelial connective tissue","longName":"3135233","preferredDefinition":"Tumor invades subepithelial connective tissue","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"8FBB4D0A-C8B5-0A8D-E040-BB89AD432FD3","latestVersionIndicator":"Yes","beginDate":"2010-09-08","endDate":null,"createdBy":"REEVESD","dateCreated":"2010-09-08","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"BE8A053C-B5E4-0643-E040-BB89AD436B32","beginDate":"2012-04-25","endDate":null,"createdBy":"COOPERM","dateCreated":"2012-04-25","modifiedBy":"ONEDATA","dateModified":"2012-04-25","deletedIndicator":"No"},{"value":"Tis","valueDescription":"Carcinoma in situ: flat tumor","ValueMeaning":{"publicId":"3442959","version":"1","preferredName":"Carcinoma in situ: flat tumor","longName":"3442959","preferredDefinition":"A flat urothelial lesion of variable thickness in the bladder, devoid of papillary structures containing cytologically malignant cells. (WHO 2016)","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Bladder Urothelial Carcinoma In Situ","conceptCode":"C37266","definition":"A flat urothelial lesion of variable thickness in the bladder, devoid of papillary structures containing cytologically malignant cells. (WHO 2016)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"BE8A053C-B5EE-0643-E040-BB89AD436B32","latestVersionIndicator":"Yes","beginDate":"2012-04-25","endDate":null,"createdBy":"COOPERM","dateCreated":"2012-04-25","modifiedBy":"COOPERM","dateModified":"2020-03-16","changeDescription":"Added concept annotation and removed special characters for MDR data migration. 3.16.20 mc","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"BE8A053C-B607-0643-E040-BB89AD436B32","beginDate":"2012-04-25","endDate":null,"createdBy":"COOPERM","dateCreated":"2012-04-25","modifiedBy":"ONEDATA","dateModified":"2012-04-25","deletedIndicator":"No"},{"value":"T0","valueDescription":"No evidence of primary tumor","ValueMeaning":{"publicId":"2981337","version":"1","preferredName":"No evidence of primary tumor","longName":"2981337","preferredDefinition":"No morphologic evidence of primary tumor, in accordance with TNM classification system guidelines.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"pT0 TNM Finding","conceptCode":"C48758","definition":"No morphologic evidence of primary tumor, in accordance with TNM classification system guidelines.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"7C86ABC7-C701-678D-E040-BB89AD432C56","latestVersionIndicator":"Yes","beginDate":"2010-01-06","endDate":null,"createdBy":"REEVESD","dateCreated":"2010-01-06","modifiedBy":"LUY","dateModified":"2015-01-29","changeDescription":"Concept annotation added for UPitt/TCGA.  Ylu, 01/29/2015.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"BE8A053C-B611-0643-E040-BB89AD436B32","beginDate":"2012-04-25","endDate":null,"createdBy":"COOPERM","dateCreated":"2012-04-25","modifiedBy":"ONEDATA","dateModified":"2012-04-25","deletedIndicator":"No"},{"value":"TX","valueDescription":"Primary tumor cannot be assessed","ValueMeaning":{"publicId":"3040286","version":"1","preferredName":"Primary tumor cannot be assessed","longName":"3040286","preferredDefinition":"A primary tumor TNM finding indicating that the status of the primary tumor cannot be assessed.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"TX TNM Finding","conceptCode":"C48737","definition":"A primary tumor TNM finding indicating that the status of the primary tumor cannot be assessed.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"83221F6F-55E7-6011-E040-BB89AD431C5D","latestVersionIndicator":"Yes","beginDate":"2010-03-31","endDate":null,"createdBy":"REEVESD","dateCreated":"2010-03-31","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":"Concept annotation added for UPitt/TCGA.  Ylu, 01/29/2015.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"BE8A053C-B61B-0643-E040-BB89AD436B32","beginDate":"2012-04-25","endDate":null,"createdBy":"COOPERM","dateCreated":"2012-04-25","modifiedBy":"ONEDATA","dateModified":"2012-04-25","deletedIndicator":"No"}],"ConceptualDomain":{"publicId":"2008549","version":"1","preferredName":"Involvement and Extent of Disease","preferredDefinition":"indication of the presence and extent of disease.","longName":"INV_AND_EXT_OF_DZ","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B22AA815-A017-5261-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-19","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-19","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"RepresentationTerm":{"publicId":"3135075","version":"1","preferredName":"Bladder Carcinoma Clinical T Stage Stage","preferredDefinition":"A carcinoma arising from the bladder epithelium.  Approximately 90% of the bladder carcinomas are transitional cell carcinomas.  The remainder are squamous cell carcinomas, adenocarcinomas and small cell neuroendocrine carcinomas.:Having to do with the examination and treatment of patients.:One criteria of the TMN staging system.  T refers to the extent of tumor involvement at the primary site (T, followed by a number indicating size and depth of invasion).:The extent of a cancer within the body, especially whether the disease has spread from the original site to other parts of the body.","longName":"C4912:C25398:C25728:C16899","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Bladder Carcinoma","conceptCode":"C4912","definition":"A carcinoma arising from the bladder epithelium.  Approximately 90% of the bladder carcinomas are transitional cell carcinomas.  The remainder are squamous cell carcinomas, adenocarcinomas and small cell neuroendocrine carcinomas.","evsSource":"CTCAE_CODE","primaryIndicator":"No","displayOrder":"3"},{"longName":"Clinical","conceptCode":"C25398","definition":"Relating to the examination and treatment of patients dependent on direct observation.  The term may also refer to the institution (clinic) providing this activity.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"T Category","conceptCode":"C25728","definition":"One criteria of the TNM staging system. T refers to the extent of tumor involvement at the primary site (T, followed by a number indicating size and depth of invasion).","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Neoplasm Stage","conceptCode":"C16899","definition":"The extent of a cancer in the body.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"8FB1B450-2DA3-E4A8-E040-BB89AD430741","latestVersionIndicator":"Yes","beginDate":"2010-09-07","endDate":null,"createdBy":"REEVESD","dateCreated":"2010-09-07","modifiedBy":"ONEDATA","dateModified":"2010-09-07","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"AJCC Based:Staging Criteria Based on American Joint Committee on Cancer System","workflowStatus":"RELEASED","registrationStatus":"Application","id":"8FB1B450-2DB4-E4A8-E040-BB89AD430741","latestVersionIndicator":"Yes","beginDate":"2010-09-07","endDate":null,"createdBy":"REEVESD","dateCreated":"2010-09-07","modifiedBy":"COOPERM","dateModified":"2020-03-16","changeDescription":"Added PVs per request by T.Lichtenberg. mc 4/25/12","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ClassificationSchemes":[{"publicId":"2756809","version":"1","longName":"TCGA (The Cancer Genome Atlas)","context":"NCIP","ClassificationSchemeItems":[{"publicId":"6044924","version":"1","longName":"Inactive CDEs as of March 2017","context":"NCIP"}]},{"publicId":"5242953","version":"1","longName":"BCAN: Bladder Cancer Advocacy Network","context":"NCIP","ClassificationSchemeItems":[{"publicId":"5242975","version":"1","longName":"UC-GENOME","context":"NCIP"}]}],"AlternateNames":[{"name":"CTEP","type":"USED_BY","context":"CTEP"},{"name":"Alliance","type":"USED_BY","context":"Alliance"}],"ReferenceDocuments":[{"name":"Clinical Assessment (TURBT an","type":"Preferred Question Text","description":"Clinical Assessment (TURBT and EUA)","url":null,"context":"NCIP"},{"name":"TCGA Comment","type":"COMMENT","description":"Includes NOS T stage","url":null,"context":"NCIP"},{"name":"CRF Text","type":"Alternate Question Text","description":"Clinical T Stage","url":null,"context":"CTEP"},{"name":"CRF Text1","type":"Alternate Question Text","description":"clinical stage","url":null,"context":"Alliance"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"8FBB4D0A-C93C-0A8D-E040-BB89AD432FD3","latestVersionIndicator":"Yes","beginDate":"2010-09-08","endDate":null,"createdBy":"REEVESD","dateCreated":"2010-09-08","modifiedBy":"TSESU","dateModified":"2018-07-17","changeDescription":"Curated for The Cancer Genome Atlas (TCGA) by request of T. Lichtenberg 9/2010","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"}}